Clin Cancer Res丨Gang An/Lugui Qiu Team First in China to Confirm Mass Spectrometry Technology for Minimally Invasive Monitoring of MRD in MM Patients Through Targeted Tracking of Serum M-Protein
Multiple Myeloma (MM), a type of blood system cancer most commonly affecting middle-aged and elderly individuals, ranks as the second most prevalent malignant hematologic tumor. Despite significant improvements in patient…








